Lichen China Limited Announces $3.1 Million Registered Direct Offering to Boost Financial Services
On December 30, 2024, Lichen China Limited, a financial and taxation service provider listed on Nasdaq under the ticker LICN, disclosed that it has successfully entered into a definitive agreement for a registered direct offering amounting to $3.1 million. This offering comprises 25 million of its Class A ordinary shares, valued at $0.125 per share, or alternatively, pre-funded warrants. This strategic move is set to enhance Lichen China’s financial positioning while complying with regulatory requirements as dictated by the United States Securities and Exchange Commission (SEC).
The securities will be sold directly to selected investors under a shelf registration statement filed by the company and declared effective on March 1, 2024. The anticipated closing date for this transaction falls on or around December 31, 2024, pending customary closing conditions. The placement agent for this offering is Univest Securities, LLC, which will facilitate the managing of the offering process. This infusion of capital comes at a critical time for Lichen China, known for providing specialized financial and taxation solutions, alongside education support and software maintenance services under its Lichen brand.
Lichen China has established a robust presence in the industry over the past 18 years, gaining recognition for delivering high-quality professional services tailored to meet the complex needs of its clients in China. The capital raised through this offering is expected to be utilized to further enhance the company’s operational capacity and expand its service offerings within the financial sector.
Additionally, Lichen China assures potential investors that this announcement is not a solicitation to buy securities nor an offer for the sale of securities in jurisdictions where such an offer could be deemed illegal. Comprehensive details regarding the offering will be elucidated in the final prospectus supplement and accompanying base prospectus, which will be accessible on the SEC's website and through Univest Securities upon request.
As Lichen China steps forward with this direct offering, it needs to navigate forward-looking statements that may involve risks and uncertainties. Investors are encouraged to consider various factors that could impact the company’s financial outlook, including market conditions and operational strategies. Lichen remains committed to transparency and adherence to regulations, continuing its mission to provide valuable financial services to its clients. For ongoing updates, stakeholders and interested parties can visit their official site, Lichen China IR, where further information will be disseminated as it becomes available.
In an evolving landscape filled with opportunities and challenging market dynamics, Lichen China’s proactive financial strategies and its robust service portfolio underscore its dedication to growth and excellence in the financial sector.
The securities will be sold directly to selected investors under a shelf registration statement filed by the company and declared effective on March 1, 2024. The anticipated closing date for this transaction falls on or around December 31, 2024, pending customary closing conditions. The placement agent for this offering is Univest Securities, LLC, which will facilitate the managing of the offering process. This infusion of capital comes at a critical time for Lichen China, known for providing specialized financial and taxation solutions, alongside education support and software maintenance services under its Lichen brand.
Lichen China has established a robust presence in the industry over the past 18 years, gaining recognition for delivering high-quality professional services tailored to meet the complex needs of its clients in China. The capital raised through this offering is expected to be utilized to further enhance the company’s operational capacity and expand its service offerings within the financial sector.
Additionally, Lichen China assures potential investors that this announcement is not a solicitation to buy securities nor an offer for the sale of securities in jurisdictions where such an offer could be deemed illegal. Comprehensive details regarding the offering will be elucidated in the final prospectus supplement and accompanying base prospectus, which will be accessible on the SEC's website and through Univest Securities upon request.
As Lichen China steps forward with this direct offering, it needs to navigate forward-looking statements that may involve risks and uncertainties. Investors are encouraged to consider various factors that could impact the company’s financial outlook, including market conditions and operational strategies. Lichen remains committed to transparency and adherence to regulations, continuing its mission to provide valuable financial services to its clients. For ongoing updates, stakeholders and interested parties can visit their official site, Lichen China IR, where further information will be disseminated as it becomes available.
In an evolving landscape filled with opportunities and challenging market dynamics, Lichen China’s proactive financial strategies and its robust service portfolio underscore its dedication to growth and excellence in the financial sector.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.